Metabolic, Pharmacokinetic, and Activity Profile of the Liver Stage Antimalarial (RC-12) is a research paper published in ACS Omega (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R21 AI103725-01
Bill and Melinda Gates Foundation
Grant: OPP1023601
Wellcome Trust
Grant: 220211
Thailand Africa and Asia Programme - GBP Core
Medicines for Malaria Venture
Grant: RD/15/022
NIAID NIH HHS
Grant: R21 AI103725
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R21AI103725-01
Leveraging RC-12 for Radical Cure of Plasmodium Vivax
Fields of Study
Sustainable Development Goals